ArisGlobal acquires Boehringer Ingelheims digital innovation BRASS
By, Admin1 min read
Share
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and ArisGlobal, the global market leader in drug safety solutions worldwide, announced the acquisition of Boehringer Ingelheim
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
